Envoy Medical, Inc.
COCH- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001840877
No open-market purchases or sales by Envoy Medical, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.9M in total; no superinvestor holds it.
Other share classesCOCHW
13F holders, Q2 2024
Institutional positions in Envoy Medical, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q1 2024
- Shares held
- 1.16M
- −11.4K (−1.0%) vs. Q1 2024
- Total value
- $2.74M
- −$1.85M (−40.3%) vs. Q1 2024
- New holders
- 8
- 3 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.9M |
| Q1 2026 | 33 | $11.5M |
| Q4 2025 | 27 | $983.0K |
| Q3 2025 | 28 | $1.65M |
| Q2 2025 | 22 | $3.28M |
| Q1 2025 | 22 | $3.00M |
| Q4 2024 | 24 | $2.95M |
| Q3 2024 | 18 | $3.33M |
| Q2 2024 | 20 | $2.74M |
| Q1 2024 | 17 | $4.59M |
| Q4 2023 | 9 | $3.01M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Envoy Medical, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 21 | $50 | 0.00% | +21 | New |
| Bank of America Corp | 57 | $135 | 0.00% | +57 | New |
| Steward Partners Investment Advisory, LLC | 726 | $1.71K | 0.00% | +726 | New |
| Royal Bank of Canada | 1,698 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,744 | $6.48K | 0.00% | +2,489+976.1% | Added |
| Advisor Group Holdings, Inc. | 3,000 | $7.08K | 0.00% | +3,000 | New |
| Tower Research Capital LLC (TRC) | 4,041 | $9.54K | 0.00% | +4,041 | New |
| UBS Group AG | 6,042 | $14.3K | 0.00% | +6,042 | New |
| BlackRock Inc. | 10,298 | $24.3K | 0.00% | +9,469+1,142.2% | Added |
| WealthTrust Asset Management, LLC | 11,316 | $26.7K | 0.02% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 11,718 | $27.7K | 0.00% | +11,718 | New |
| Northern Trust Corp | 14,043 | $33.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 23,872 | $56.3K | 0.00% | −11,200−31.9% | Reduced |
| Morgan Stanley | 31,541 | $74.4K | 0.00% | 00.0% | Unchanged |
| CI Private Wealth, LLC | 38,162 | $90.1K | 0.00% | +38,162 | New |
| Polar Asset Management Partners Inc. | 80,000 | $188.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 86,959 | $205.3K | 0.00% | −3,017−3.4% | Reduced |
| Vanguard Group Inc | 115,928 | $273.6K | 0.00% | +17,538+17.8% | Added |
| HighTower Advisors, LLC | 164,322 | $388.0K | 0.00% | 00.0% | Unchanged |
| Atlas Merchant Capital LLC | 555,527 | $1.31M | 0.67% | −43,892−7.3% | Reduced |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,045−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,555−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,637−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −344−100.0% | Sold out |